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A bifurcated stent graft device was successfully deployed to exclude an asymptomatic abdominal aortic aneurysm (AAA)
with adequate proximal aortic neck morphology. At 6 months, a type II endoleak was successfully embolized through a
proximal perigraft channel with metallic coils. The patient was seen with upper gastrointestinal bleeding and a pulsatile
abdominal mass 11 months later. Surgical exploration revealed an aortoduodenal fistula in the vicinity of the previous
embolization. We discuss the possible causes of this complication and review the literature on the subject. We conclude
that aortoduodenal fistula can occur after endovascular AAA repair despite the absence of endoleak or AAA diameter
increase on follow-up computed tomographic scan. (J Vasc Surg 2003;37:461-4.)
Endovascular repair (EVAR) of abdominal aortic aneu-
rysm (AAA) is an emerging technique that could offer a less
invasive alternative to conventional open surgery. Encour-
aging early and midterm results have been reported in spite
of periprosthetic endoleaks. However, long-term benefits
are still under evaluation. Absence of endograft incorpora-
tion,1,2 kinking of the endograft after aneurysm shrinkage,3
and persistence of pressurized AAA sacs without evidence
of endoleaks4,5 question the durability and safety of this
treatment with the currently available devices. We report
the case of a patient with an aortoduodenal fistula 17
months after successful endovascular AAA repair.
CASE REPORT
A 75-year-old woman was referred to our center in December
1997 after the discovery of a 4.4-cm asymptomatic infrarenal AAA.
The patient was followed with serial abdominal ultrasound scan
until May 1999 when the aneurysm diameter had increased to 5.5
cm. Computed tomographic (CT) scan and angiogram both con-
firmed that the aneurysm was morphologically suitable for EVAR,
having a 20 mm-long, tubular, noncalcified, and nonangulated
proximal aortic neck. No signs of inflammatory aneurysm were
found. The serum creatinine level was 118 mmol/L. After in-
formed consent was obtained, a Talent bifurcated device
(Medtronic, Sunrise, Fla) with a 24-mm main body and 12-mm
iliac diameter was deployed via transverse common femoral arteri-
otomies in October 1999 without complications. The intraopera-
tive completion angiogram confirmed adequate deployment of the
device with the proximal bare portion of the stent at the level of
ostia of the renal arteries. A CT scan done 48 hours later showed a
minor lumbar type II endoleak. The patient was discharged from
the hospital on the fifth postoperative day.
The 1-month follow-up CT scan showed no increase in aneu-
rysm diameter and spontaneous sealing of the type II endoleak.
The 6-month follow-up CT scan in May 2000 showed stable
aneurysm diameter but evidence of a new posterior endoleak. An
angiogram was done that confirmed the presence of a type II
lumbar endoleak. Embolization of the ascending branches of the
right iliolumbar artery and superior gluteal arteries with 355- to
500- particles (Contour, Target Therapeutics, Fremont, Calif)
failed to eradicate the endoleak. A lymphocele in the left groin
(140 mL) was evacuated 1 week later, and culture of the lymph
fluid showed 3 presence of coagulase-negative Staphylococcus.
Two weeks later, embolization of the left iliolumbar artery was
attempted from the left common femoral artery without success
because of inability to catheterize the left iliolumbar artery. It was
decided to perform a catheterization of the aneurysmal sac via a left
axillary artery approach. A 3F coaxial catheter was advanced be-
tween the prosthesis and the aortic wall to embolize the right
posterolateral portion of the AAA sac with 0.018-in coils (Vortx,
Target Therapeutics, Fremont, Calif) and thrombin (1000 units;
Thrombostat, Parke-Davis, Scarborough, Ontario, Canada). A
control CT scan 24 hours later showed small air bubbles around
the coils with no residual endoleak (Fig 1). A follow-up CT scan
done 3 months later, in September, showed no endoleak, no
increase in aneurysm diameter, and no residual air around the coils.
The patient consulted shortly thereafter in another hospital for
abdominal malaise, anorexia, and asthenia. Unexplained acute
renal insufficiency was diagnosed, and the patient was referred to a
nephrologist. A CT scan done in November revealed no signs of
intraabdominal pathology and no abnormalities related to the
endoprosthesis. Both kidneys were normally perfused, and AAA
size was stable with no evidence of endoleak and no sign of
endoprosthesis migration or infection. In March 2001, the patient
consulted again for new onset of diarrhea. The patient also had
nausea, vomiting, fever, and anorexia with a 30-lb weight loss over
the preceding 6 months. The hemoglobin level, white cell count,
and creatinine level were 83 g/dL, 2700/mm3, and 147 mmol/L,
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respectively. Urinalysis results were normal. Twenty-four hours
after admission to hospital, severe upper gastrointestinal bleeding
with hematemesis and melena developed. An upper gastrointesti-
nal endoscopy showed an adherent clot in the third portion of the
duodenum. The patient was immediately transferred to our insti-
tution for a suspected aortoduodenal fistula.
On arrival, the patient was transferred to the intensive care
unit in hemorrhagic shock. Physical examination revealed a pulsa-
tile mass. An urgent CT scan showed massive retroperitoneal air
around the endoprosthesis within the aneurysm and a retroperito-
neal hematoma (Fig 2). The right kidney was atrophic without
nephrogram. A plain abdominal radiograph showed no apparent
change or metallic disruption. The patient was brought to the
operating room and underwent an axillobifemoral bypass. At lap-
arotomy, there was no hemoperitoneum. The retroperitoneal tis-
sues anterior to the aneurysm were thickened and inflamed, and
the AAA was pulsatile. The duodenum was adherent to the lateral
portion of the aneurysm. After clamping of the suprarenal aorta
and both common iliac arteries, the aneurysmal sac was opened.
The endoprosthesis appeared intact with no disruption of its body
or its attachment to the left iliac branch. However, it had migrated
proximally and covered the origin of the right renal artery but had
not perforated the aortic wall. On its right side below the aortic
neck, we found the cavity that had been embolized previously. This
cavity was stained with bile, contained multiple coils, some of
which were embedded in the aortic wall, and communicated with
the third portion of the duodenum through a 1-cm fistula. No
bleeding was noted at the level of the cavity. The endoprosthesis
was not incorporated to the surrounding aortic wall, with possible
poor proximal sealing, and was easily removed in its proximal
portion at the level of the aortoduodenal fistula (Fig 3). An
infrarenal aortic stump was created and covered with greater
omentum. The duodenal fistula was closed, and the region was
drained. Unfortunately, the patient died 12 hours later in refrac-
tory septic shock.
Culture results of sample taken from within the aneurysm sac
revealed mixed aerobic and anaerobic flora (coagulase-negative
Staphylococcus, nonenterococcal group D Streptococcus, Prevotella
melaninogenica, Fusobacterium nucleatum, Bacteroides uniformis,
and Fragilis and Peptostreptococcus micros). Ex vivo macroscopic
examination of the stent graft revealed no structural fractures, but
a small tear was found in the fabric, probably of iatrogenic origin
during the operation.
DISCUSSION
Secondary aortoenteric fistula is a rare complication of
open AAA repair. The incidence rate of this complication
after EVAR is unknown. To our knowledge, five other cases
of aortoenteric fistula occurring 5 to 22 months after
endovascular AAA repair have been reported. In the ab-
sence of an anastomosis suture line, three distinct situations
in which this complication was reported may help to un-
derstand the pathophysiology of fistula formation after
EVAR.
In two instances, aortoenteric fistula formation was
reported in patients with a preexisting inflammatory pro-
cess around the aneurysm shown on CT scan. The first case
was reported in 1998 by Norgren, Jernby, and Engellau.6
The complication occurred 17 months after a successful
endovascular AAA procedure with a first generation Sten-
tor device (MinTec, Ltd, Freeport, The Bahamas). In the
second case, the aortoenteric fistula occurred 7 months
after apparent successful AAA exclusion with an AneuRx
device (Medtronic AVE, Santa Rosa, Calif) with no appar-
ent mechanical stent failure, distortion, or migration.7 In
both cases, the etiology of the periaortic inflammatory mass
was uncertain, but the resolution of the inflammatory pro-
cess before the complication occurrence lends support to
the diagnosis of an inflammatory rather than a mycotic
aneurysm. However, the pathogenic mechanism responsi-
ble for the fistula in these cases remains unknown, and
stenting of a primarily infected AAA cannot be excluded.
Poor fixation and poor sealing were also identified as
possible causes of fistula formation.8,9 Hausegger et al8
reported an aortoduodenal fistula occurring 20 months
after EVAR. This patient had marked angulation of the
proximal neck that resulted into migration and kinking of
the device against the anterior wall of the aneurysm. Sub-
sequent erosion of the aortic wall by the stent graft was
proposed as a potential cause of fistula formation. The
upper section of the bifurcated Vanguard device (Boston
Scientific, Watertown, Mass) was found to be disconnected
as a result of suture disruption. d’Othee et al9 reported a
similar case with proximal aortic neck enlargement result-
ing in fixation failure. Device migration and fracture and
repressurization of the aneurysmal sac led to erosion of the
aortic wall.
Finally, primary stent graft infection has also been
proposed as the possible cause of aortoenteric fistula for-
mation 5 months after EVAR in a patient admitted to
Fig 1. CT scan 24 hours after coil embolization showed small air
bubbles around coils with no residual endoleak.
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hospital with pneumonia and no radiologic evidence of
endoleak, increase in aneurysm size, stent migration, or
device failure.10 According to the authors, an infected stent
graft may have led to septic aortitis and subsequent fistula
formation.
In this case, there were no clinical or radiologic signs of
a primary aortoduodenal fistula before EVAR. Despite the
apparent successful AAA exclusion from blood flow and the
absence of detectable endoleak or increase in AAA diameter
on follow-up CT scan performed 4 months previously, the
patient was seen 17 months after EVAR with an aortoduo-
denal fistula that resulted in death. Of interest, the fistula
was found to be in communication with the AAA sac at the
level of the cavity embolized 9 months before treatment of
a type II endoleak. Coils embedded in the aortic wall and
stained with bile were found in proximity to the fistula
orifice. These findings suggest a relation between the treat-
ment of the type II endoleak and the subsequent aortoduo-
denal fistula.
The significance of type II endoleak remains uncertain.
Recent reports indicate that type II endoleaks are not
associated with a higher risk of AAA rupture or conversion
and that treatment should therefore only be performed in
case of increase in aneurysm size.11 In this case, the fistula
formation may be a complication of the type II endoleak
treatment. The disappearance of air bubbles after the last
embolization and the absence of radiologic signs suggest-
ing infection on the September and November CT scans
indicate that a virulent infectious process primarily respon-
sible for this complication is less probable. However, a
low-grade infection of the stent graft and aortic wall cannot
be excluded. The treatment of an infected lymphocele in
the left groin 1 week before the two endoleak embolization
procedures, one of which was done through the left groin,
Fig 2. CT scan at 17 months showed massive retroperitoneal air around endoprosthesis within aneurysm and
retroperitoneal hematoma.
Fig 3. Talent endoprosthesis after surgical explant.
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may have resulted in infectious contamination during the
procedure. Coagulase-negative Staphylococcus was cultured
from both the lymphocele and the aneurysm sac. Also, an
injury to the aortic wall or prosthesis during the emboliza-
tion procedure cannot be excluded, although manipulation
with a 3F microcatheter and embolization with soft
0.018-in coil is unlikely to be traumatic. The presence of
metallic coils embedded into the aortic wall in the region of
the fistula suggests that chronic and repetitive aortic wall
trauma may have occurred. Pulsatility of the stent graft
device or endotension in the sac may have exacerbated the
wall injury from the metallic coils. The combination of
aortic wall injury and septic aortitis may explain fistulization
into the duodenum.
The endoleak treatment done through a periprosthetic
track may have resulted in endotension from an occult,
incomplete seal of the proximal anchoring system.12-16
Successful endoleak embolization through direct translum-
bar puncture of the aneurysm sac was reported by several
authors, thereby avoiding catheterization of the proximal
attachment zone.17 The proximal migration of the device
indicates poor fixation despite the ideal aortic neck mor-
phology in this patient and despite the bare stent portion of
the Talent graft. Poor fixation may be inherent to inade-
quate fixation with this technology or the results of infec-
tious aortitis, neck enlargement, or periprosthetic passage
during treatment of type II endoleak.
We conclude that aortoduodenal fistulization and an-
eurysm rupture can occur after EVAR despite the absence
of detectable endoleak or increase in AAA diameter on
follow-up CT scan. The findings in this case suggest that
aortoduodenal fistulization could be a complication of
treatment of a type II endoleak. Metallic coils within the
AAA sac and embedded within the aortic wall may have
produced chronic repetitive aortic wall injury from pulsa-
tion of the stent graft device or endotension and may have
led to fistulization and aneurysm rupture. Clinical and
radiologic follow-up every 6 months after EVAR did not
permit early detection and prevention of this fatal compli-
cation.
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